Skip to main content

JPMORGAN CHASE & CO

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 19617 NEW YORK, NY

Position in KNSA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,017,811
-$3,135,055 QoQ
Shares Held
31,553
-70.5% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. KNSA ranks #28 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,017,811 31,553
2026-03-31 $5,152,866 107,017
2025-12-31 $1,996,376 48,397
2025-09-30 $7,473,064 192,456
2025-06-30 $3,743,251 135,282
2025-03-31 $2,585,507 116,412
2024-12-31 $9,450,880 477,800
2024-09-30 $4,997,324 199,973